Embedded Files
Dila Kaymaz, BSc
Master of Science in Biomedical Sciences University of Bern 13.02.2025
Next-generation CAR T cells targeting FGFR4 for pediatric rhabdomyosarcoma
Co-supervision - Caroline Piccand, MSc.
Osama Losego, BSc
September 2023 - May 2024
Master work - Master of Sciences in Life Sciences FHNW
Andrea Timpanaro, PhD
Andrea Timpanaro, PhD
PhD Defense 29.11.2022
PhD student 1.8.2018 -31.12.2022
Thesis: Chimeric Antigen Receptor (CAR) T cell therapy for rhabdomyosarcoma: novel targets identified by surfaceome profiling and promising pre-clinical efficacy targeting CD276 and FGFR4
Current position:
Postdoctoral Researcher at Ben Towne Center for Childhood Cancer Research, Seattle Children’s Hospital in Nic Vitanza's Lab
Dzhangar Dzhumashev, PhD
Dzhangar Dzhumashev, PhD
PhD Defense 21.10.2022
PhD student 1.8.2018 -31.10.2022
Thesis: Liposomal targeted drug delivery to rhabdomyosarcoma
Current Position: University of Geneva, Prof. Dennis Migliorini's lab
Caroline Piccand, MSc
Caroline Piccand, MSc
Master of Science in Biomedical Sciences - 31 January 2022
Characterization of CAR T cells targeting CD276 in rhabdomyosarcoma
(07.2021 - 01.2022)
Co-Supervisor: Andrea Timpanaro
Current position: PhD student in our lab.
Rita Sala Faig, PhD
Rita Sala Faig, PhD
Postdoc 1.1.2021-31.12.2021
Current position:
Postdoctoral fellow at the University of Colorado, Anschutz Medical Campus, Skaggs School of Pharmacy and Pharmaceutical Sciences
Andrea Robbi
Andrea Robbi
Master of Science in Pharmacy - 2 July 2021
Generation, Validation, and Comparison of 2nd and 3rd generation Chimeric Antigen Receptors (CARs) targeting CD276 in Rhabdomyosarcoma cell lines (01.2021 - 07.2021)
Co-Supervisor: Andrea Timpanaro
Safa Ali
Safa Ali
Master of Science in Pharmacy - 16 July 2021
Formulation and optimization of NCAM-1 targeted liposomes: in vitro testing (01.2021 - 07.2021)
Co-Supervisor: Dzhangar Dzhumashev
Janine Moser
Janine Moser
Master of Science in Pharmacy - 30 July 2021
Master of Science in Pharmacy - 30 July 2021
Investigation of the activation capacity and specificity of novel Chimeric Antigen Receptor (CAR) constructs targeting surface proteins on Rhabdomyosarcoma (01.2021 - 0.8.2021)
Co-Supervisor: Andrea Timpanaro
Page updated
Google Sites
Report abuse